Skip to main content

Table 1 Intensity of systemic and local reactions

From: An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial

 

Intensitya

Group I accelerated (N = 61)

Group II conventional (N = 61)

Systemic reaction

Mild

8 (13.1 %)

2 (3.3 %)

Moderate

0 (0.0 %)

2 (3.3 %)

Severe

0 (0.0 %)

0 (0.0 %)

Injection site swelling

Mild

10 (16.4 %)

5 (8.2 %)

Moderate

2 (3.3 %)

1 (1.6 %)

Severe

1 (1.6 %)

0 (0.0 %)

Injection site erythema

Mild

10 (16.4 %)

7 (11.5 %)

Moderate

1 (1.6 %)

0 (0.0 %)

Severe

0 (0.0 %)

0 (0.0 %)

  1. aEach patient counted once under the highest intensity